These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19850592)

  • 21. Inhibin secretion in women with the polycystic ovary syndrome before and after treatment with progesterone.
    Dafopoulos K; Venetis C; Messini CI; Pournaras S; Anifandis G; Garas A; Messinis IE
    Reprod Biol Endocrinol; 2011 Apr; 9():59. PubMed ID: 21529351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility.
    Laven JS; Imani B; Eijkemans MJ; de Jong FH; Fauser BC
    Hum Reprod; 2001 Jul; 16(7):1359-64. PubMed ID: 11425813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation.
    Yong PY; Baird DT; Thong KJ; McNeilly AS; Anderson RA
    Hum Reprod; 2003 Jan; 18(1):35-44. PubMed ID: 12525438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follicle-stimulating hormone induces dose-dependant stimulation of immunoreactive inhibin secretion during the follicular phase of the human menstrual cycle.
    Hee JP; MacNaughton J; Bangah M; Zissimos M; McCloud PI; Healy DL; Burger HG
    J Clin Endocrinol Metab; 1993 May; 76(5):1340-3. PubMed ID: 8496327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pharmacodynamic comparison of human urinary follicle-stimulating hormone and human menopausal gonadotropin in normal women and polycystic ovary syndrome.
    Anderson RE; Cragun JM; Chang RJ; Stanczyk FZ; Lobo RA
    Fertil Steril; 1989 Aug; 52(2):216-20. PubMed ID: 2502437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women.
    Burger HG; Cahir N; Robertson DM; Groome NP; Dudley E; Green A; Dennerstein L
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):809-13. PubMed ID: 9713572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased inhibin B responses following recombinant human chorionic gonadotropin administration in normal women and women with polycystic ovary syndrome.
    Shayya RF; Rosencrantz MA; Chuan SS; Cook-Andersen H; Roudebush WE; Irene Su H; Shimasaki S; Chang RJ
    Fertil Steril; 2014 Jan; 101(1):275-9. PubMed ID: 24188875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of androgen blockade on granulosa cell estradiol production after follicle-stimulating hormone stimulation in women with polycystic ovary syndrome.
    Mehta RV; Malcom PJ; Chang RJ
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3503-6. PubMed ID: 16804036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone.
    Welt CK; Taylor AE; Martin KA; Hall JE
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5559-65. PubMed ID: 12466353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling.
    Weerakiet S; Lertvikool S; Tingthanatikul Y; Wansumrith S; Leelaphiwat S; Jultanmas R
    Gynecol Endocrinol; 2007; 23(8):455-60. PubMed ID: 17852413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels.
    Sehested A; Juul AA; Andersson AM; Petersen JH; Jensen TK; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1634-40. PubMed ID: 10770209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum inhibin B in polycystic ovary syndrome as a potential marker of ovarian dysfunction].
    Cetković A
    Srp Arh Celok Lek; 2008; 136(7-8):379-83. PubMed ID: 18959173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproductive ageing and ovarian function: is the early follicular phase FSH rise necessary to maintain adequate secretory function in older ovulatory women?
    Hansen KR; Thyer AC; Sluss PM; Bremner WJ; Soules MR; Klein NA
    Hum Reprod; 2005 Jan; 20(1):89-95. PubMed ID: 15550499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of inhibin B and inhibin a by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles.
    Welt CK; Schneyer AL
    J Clin Endocrinol Metab; 2001 Jan; 86(1):330-6. PubMed ID: 11232020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.
    Guedikian AA; Lee AY; Grogan TR; Abbott DH; Largaespada K; Chazenbalk GD; Dumesic DA
    Fertil Steril; 2018 Mar; 109(3):508-515. PubMed ID: 29428312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome.
    Eldar-Geva T; Ben-Chetrit A; Spitz IM; Rabinowitz R; Markowitz E; Mimoni T; Gal M; Zylber-Haran E; Margalioth EJ
    Hum Reprod; 2005 Nov; 20(11):3178-83. PubMed ID: 16113044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unkeito promotes follicle development by restoring reduced follicle-stimulating hormone responsiveness in rats with polycystic ovary syndrome.
    Yoshita S; Osuka S; Shimizu T; Fujitsuka N; Matsumoto C; Bayasula ; Miyake N; Muraoka A; Nakanishi N; Nakamura T; Goto M; Kajiyama H
    Front Endocrinol (Lausanne); 2023; 14():1228088. PubMed ID: 37790609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced granulosa cell responsiveness to follicle-stimulating hormone during insulin infusion in women with polycystic ovary syndrome treated with pioglitazone.
    Coffler MS; Patel K; Dahan MH; Yoo RY; Malcom PJ; Chang RJ
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5624-31. PubMed ID: 14671144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F; Liu XL; Rong N; Huang XW
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.